I agree Hosai. On top of that the US market for AD is growing at a 10% CAGR and the European market is growing at close to a 12.5% CAGR. It is very plausible to arrive at a sp above $1,000. Those who don't believe need to check their math. Missling is not going to just give this away.
Mayo doesn't know jack shit; he is a pumper. The idiot said it would be approved and commercialized in 2022 with a $6000/share valuation. How much money did you donate to his world tour?
All trials have failed; Rett proved that this drug is nothing more than a sugar pill. Misleading can't get a single thing done on time. The clown blabbers and says whatever comes to his mind during the CC. One has to read the CC transcript four times to make sense of what he is trying to say. Company has no strategy and plan, it is all circus.
Market Data 
Markets 
